Prospective evaluation of a prognostic index for intrinsic supratentorial tumours In their paper published in this J7ournal
Hutton et al conclude that histological grade provided no additional information on survival of patients with intrinsic supratentorial tumours.1 This is surprising and contrary to the findings of other workers.>' One of the problems is that they relied on the Kernohan grading system, which is notoriously subjective. Other groups have pointed out that histological grade using the Daumas-Duport scheme does contribute prognostic information. It would be interesting to know whether if the prognostic index used by the current authors was tested against the Daumas-Duport scheme, histology would still fail to contribute to the prognostic index.
Hutton et al reply: That histological grade provided no additional information on survival once a binary variable derived from our index was taken into account is a statement of fact. As Dr Hedley-Whyte is surprised by this fact, we suggest that she uses the index, given in the paper, on data which she has collected. It will be interesting to know whether the Daumas-Duport scheme contributes prognostic information which adds to data that can be obtained by non-invasive methods.
Hemibaflism in Parkinson's Disease
We read with interest the recent interchange between Obeso et al and Inzelberg and Korczyn in the J7ournal (1995;58:645-6) .
Their discussion, and particularly the accompanying diagrams, outline current wisdom with respect to basal ganglia interactions and how changes in the activity of specific structures account for certain clinical manifestations. One critical clinical observation which is not readily explained by the current physiological models of the basal ganglia is the striking amelioration of levodopa-induced dyskinesiae with ventral posterior medial pallidotomy. The benefit obtained from this procedure with respect to primary parkinsonian signs is generally explained on the basis of a reduction in the overactivity of the GABAergic inhibitory input from the pars interna (GPi) to the thalamus ( fig 2B, p 646 ). However, given the extent of the expected pallidal lesioning with this procedure, a pronounced reduction would have been expected in all pallidal outflow resulting in a similar picture to that depicted in fig 2F ( similar to an extensive lesion in the subthalamic nucleus (STN) causing dyskinesia). Instead, in our experience, mild, shortlived (< one hour) contralateral (and occasional ipsilateral) dyskinesiae occur at the time of lesioning in most patients followed by almost complete elimination of all forms of levodopa-induced dyskinesiae (peak dose dyskinesiae, diphasic dyskinesiae, and off period dystonia) in the contralateral limbs with additional improvements often seen in ipsilateral limbs as well. If the lesion is misplaced or partial (possibly comparable with the effects proposed in fig  2E with a partial STN lesion), the ameliorative effects of the pallidotomy on levodopa induced dyskinesiae may be only shortlived.
There are other important neuroanatomical problems with the simplified schematic diagrams currently used to explain these clinical states. Figure 2 outlines the "indirect pathway" exclusively. However, as Parent and Hazrati' 2 have recently pointed out, there are major anatomical flaws in this simplification. These authors argue that the projection from the external segment of the globus pallidus (GPe) to the STN does not directly synapse with neurons projecting on to the GPi and substantias nigra (SN) pars reticulata. Instead, they connect with neurons which project back to the GPe forming a closed loop. The GPe then has a direct connection to the GPi which is all but ignored in current anatomical formulations. Another important criticism of current models emphasised by Parent and Hazrati'2 is the fact that the STN input to the GPi projects predominantly to neurons involved in associative rather than sensorimotor striatal inputs.
It is clear that there is a great deal more to be learned about the interactions of corticobasal ganglia-thalamocortical interactions in health and disease states. Although current models have successfully predicted some clinical findings, they fall well short of satisfactorily explaining many others. Careful electrophysiological, biochemical, and imaging assessments of non-human primates and patients undergoing surgical treatments for Parkinson's disease will hopefully assist in clarifying some of these confounding issues. included. The advice seems coherent and sensible, although an interesting omission was pizotifen from the list of migraine prophylactics (perhaps reflecting North American practice). Undoubtedly it is superficial, sometimes to the point of being unhelpful; surely Professors will moan. But then The Manual is not for them. Their registrars however may want to slip a copy into their white coat on the way to clinic, alongside that lucky tendon hammer and Aids to the Examination of the Peripheral Nervous System. This may not be the biggest text book on migraine but it is one of the better ones. The middle section, on the pathophysiology of migraine, is particularly good. You will have to look hard to find such a comprehensive, up-to-date and well-referenced discussion of this difficult and often bewildering subject. Vascular, neural, and other theories of migraine pathogenesis are covered logically, in depth and with authority over some 65 pages. It is perhaps no surprise to see that the author is not only a professor of neurology but professor of physiology, biophysics, and molecular and cellular pharmacology as well.
The first section critically reviews the epidemiology and diagnostic criteria for migraine, its myriad variations and trigger factors. Other headache syndromes are described and put in context but it is clear that this is a text book on migraine and not headache. Some Ill pages and about a third of the book's 2210 references cover this initial section.
The final section, on the treatment of patients with migraine, is of no lesser quality. As one might expect from a single authored text book there is again consistency, lack of duplication or overlap in the text. From the emphasis on the drugs described one can deduce that the author is American, with much on calcium antagonists and little on good old pizotifen. Thanks to advances in neuroscientific research, neuropsychiatry is currently resurgent, but for the clinician it has the potential weakness of concentrating on "lesions" and "impairments", with the risk of neglecting the whole patient and his or her social environment. This pitfall seems even more possible in "geriatric" neuropsychiatry with its backdrop of inevitable decline into senescence. So it is rather gloomy reading that everything gets worse with age, and at variance with the positive aspects of elderly people (dignity, wisdom, etc) and the great satisfaction to be gained from treating them as patients.
Following this conceptual grumble, I shall now praise this weighty red book. It is very thorough and informative, with extensive reviews of the neuropsychiatry of both psychiatric and neurological disorders, but also more general sections on aging, neuropsychology, neuroimaging, and neuropsychopharmacology. The chapters are contributed by leading American researchers and the format and standard are generally uniformly high. In some areas (for instance, anxiety, epilepsy), there is little neuropsychiatric research specifically relating to the elderly, but the relevance of the literature to old age is always emphasised. Perhaps the chapters on psychiatric disorders are less satisfactory than those concerning neurological illnesses the discussion on mood disorders concentrates on neuropsychiatric aspects and secondary depression at the expense of ordinary major depression and (especially) its prognosis.
Large books suffer in areas of rapid technical advance, and this volume is already out of date on such topics as apolipoprotein E and tacrine. Nonetheless, it is a mine of information and will be a valuable source of reference for some time yet. ders in the elderly. I attended the course and now reviewing the book I find myself like the cinema-goer who saw the film before reading the book.
The book is divided into three parts, an update on the dementias (Cortical Lewy body dementia, vascular dementia, and the genetics of Alzheimer's), drug trials in dementia, and the management of functional disorders (novel psychotics in the elderly, a review of antidepressants in the elderly, day hospitals). The book provides a relevant and balanced mix of basic science contributions and clinical issues. As with many multi-authored books style alters considerably but overall the standard is high, chapters are clearly written, and topics thoroughly reviewed by leading researchers and well-known clinicians.
Although a number of chapters, which at the time written presented state of the art work, will no doubt quickly date, the clinical chapters will provide good advice for some while.
At £35.00 a copy this book should without doubt be on the library shelf but I would also recommend it to old age psychiatrists and trainees for their personal library. It also has much of interest for geriatricians and adult psychiatrists. It certainly is a lot better than the notes I took! 
